Detalhe da pesquisa
1.
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.
Hepatology
; 73(3): 1061-1073, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32946600
2.
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.
Hepatology
; 73(3): 1074-1087, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32464706
3.
Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol
; 19(5): 1067-1070.e2, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32360820
4.
Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium.
J Pediatr Gastroenterol Nutr
; 71(4): 459-464, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32740528
5.
Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children.
J Pediatr Gastroenterol Nutr
; 70(1): e12-e17, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31651664
6.
The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Hepatology
; 66(2): 518-527, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28390159
7.
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).
J Pediatr Gastroenterol Nutr
; 64(2): 319-334, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28107283
8.
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.
Aliment Pharmacol Ther
; 59(10): 1236-1247, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38462727
9.
Response to the Letters Regarding the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition NAFLD Guidelines.
J Pediatr Gastroenterol Nutr
; 65(5): e115-e116, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29059122
10.
Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations.
J Pediatr Gastroenterol Nutr
; 55(1): 93-108, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22516861
11.
Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).
J Pediatr
; 172: 9-13, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26749112
12.
Case 1: Cholestatic jaundice in an infant with Down syndrome.
Paediatr Child Health
; 20(6): 289-91, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26435664
13.
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
Hepatol Commun
; 2(11): 1369-1378, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30411083
14.
Nonalcoholic fatty liver disease (NAFLD) in children.
Curr Opin Pediatr
; 14(5): 593-600, 2002 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-12352254